These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16480587)

  • 41. Association of transforming growth factor-beta1 gene polymorphisms with genetic susceptibility to nasopharyngeal carcinoma.
    Wei YS; Zhu YH; Du B; Yang ZH; Liang WB; Lv ML; Kuang XH; Tai SH; Zhao Y; Zhang L
    Clin Chim Acta; 2007 May; 380(1-2):165-9. PubMed ID: 17368597
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical analysis and long-term follow up study of asymptomatic nasopharyngeal carcinoma patients].
    Ji MF; Guo YQ; Zheng SA; Liang JS; Wang DK; Ou XT
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2003 Feb; 38(1):53-6. PubMed ID: 12778770
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk factors for nasopharyngeal carcinoma.
    Lin TM; Chang HJ; Chen CJ; Cheng YJ; Yang CS; Tu SM; Ito Y; Kawamura A; Hirayama T
    Anticancer Res; 1986; 6(4):791-6. PubMed ID: 3752958
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Expression and clinical significance of VEGF and its receptors Flt-1 and KDR in nasopharyngeal carcinoma].
    Sha D; He YJ
    Ai Zheng; 2006 Feb; 25(2):229-34. PubMed ID: 16480593
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Mucoepidermoid carcinoma of nasopharynx: a report of twelve cases].
    Qiu F; Hua YJ; Guo L; He JH; Qiu XL; Hong MH
    Ai Zheng; 2005 Mar; 24(3):362-4. PubMed ID: 15757543
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IgA/VCA as a follow-up marker in the monitoring of nasopharyngeal carcinoma.
    Sam CK; Abu-Samah AJ; Prasad U
    Eur J Surg Oncol; 1994 Oct; 20(5):561-4. PubMed ID: 7926060
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic value of Survivin and Livin in nasopharyngeal carcinoma.
    Xiang Y; Yao H; Wang S; Hong M; He J; Cao S; Min H; Song E; Guo X
    Laryngoscope; 2006 Jan; 116(1):126-30. PubMed ID: 16481824
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epstein-Barr virus immune response in high-risk nasopharyngeal carcinoma families in Greenland.
    Friborg J; Jarrett RF; Liu MY; Falk KI; Koch A; Olsen OR; Duncan P; Wohlfarht J; Chen JY; Melbye M
    J Med Virol; 2007 Dec; 79(12):1877-81. PubMed ID: 17935169
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical hereditary characteristics in nasopharyngeal carcinoma through Ye-Liang's family cluster.
    Zhang F; Zhang J
    Chin Med J (Engl); 1999 Feb; 112(2):185-7. PubMed ID: 11593591
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The xeroderma pigmentosum group C gene polymorphisms and genetic susceptibility of nasopharyngeal carcinoma.
    Yang ZH; Liang WB; Jia J; Wei YS; Zhou B; Zhang L
    Acta Oncol; 2008; 47(3):379-84. PubMed ID: 17882560
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma.
    Li YH; Hu CF; Shao Q; Huang MY; Hou JH; Xie D; Zeng YX; Shao JY
    J Transl Med; 2008 Jan; 6():1. PubMed ID: 18171482
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Early diagnosis of nasopharyngeal carcinoma using recombinant antigens expressed in bacteria].
    Wan Z; Pi G; Sun N
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):74-6. PubMed ID: 12515179
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Symptoms and prognosis of nasopharyngeal carcinoma].
    Yi JL; Gao L; Huang XD; Li SY; Luo JW; Xu GZ; Xiao JP; Cai WM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):315-7. PubMed ID: 16900622
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Macrophage inflammatory protein-3alpha is a novel serum marker for nasopharyngeal carcinoma detection and prediction of treatment outcomes.
    Chang KP; Hao SP; Chang JH; Wu CC; Tsang NM; Lee YS; Hsu CL; Ueng SH; Liu SC; Liu YL; Wei PC; Liang Y; Chang YS; Yu JS
    Clin Cancer Res; 2008 Nov; 14(21):6979-87. PubMed ID: 18980993
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983-2002) in Sihui and Cangwu counties in southern China.
    Jia WH; Huang QH; Liao J; Ye W; Shugart YY; Liu Q; Chen LZ; Li YH; Lin X; Wen FL; Adami HO; Zeng Y; Zeng YX
    BMC Cancer; 2006 Jul; 6():178. PubMed ID: 16822324
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Independent effect of EBV and cigarette smoking on nasopharyngeal carcinoma: a 20-year follow-up study on 9,622 males without family history in Taiwan.
    Hsu WL; Chen JY; Chien YC; Liu MY; You SL; Hsu MM; Yang CS; Chen CJ
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1218-26. PubMed ID: 19336547
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Some epidemiologic observations of nasopharyngeal carcinoma in Guangdong, People's Republic of China.
    Li CC; Yu MC; Henderson BE
    Natl Cancer Inst Monogr; 1985 Dec; 69():49-52. PubMed ID: 3834344
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Frequent allelic loss at the FRA3B site in endemic nasopharyngeal carcinoma: association with clinical features and Epstein-Barr virus infection.
    Deng YF; Zhou DN; Lu YD
    J Laryngol Otol; 2007 Nov; 121(11):1073-8. PubMed ID: 17359554
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Expression and clinical significance of vascular endothelial growth factor C and D in nasopharyngeal carcinoma].
    Zhao GG; Xiang XJ; He YJ
    Ai Zheng; 2007 Jan; 26(1):90-5. PubMed ID: 17222375
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of Epstein-Barr virus genotypes and clinicohistopathological features of nasopharyngeal carcinoma between Guilin, China and Fukuoka, Japan.
    Zhou Y; Nabeshima K; Koga K; Aoki M; Hayashi H; Hamasaki M; Iwasaki H
    Oncol Rep; 2008 Jun; 19(6):1413-20. PubMed ID: 18497945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.